Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2
The Journal of Allergy and Clinical Immunology, 06/15/2012
Novak N et al. – Immunosilencing of FcεRI–activated basophils by means of selective suppression mediated by H2R might be highly relevant for the very early induction of allergen tolerance and the so–called desensitization effect of venom immunotherapy (VIT).



